Clinical Trials at Fairfield Medical Center
As of August 2026, 14 paid clinical trials are recruiting at Fairfield Medical Center, located at 401 N EWING ST, LANCASTER, OH 43130-3372, phone (740) 687-8000 in Lancaster, Ohio. Active studies at this site cover conditions such as Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8 and Acral Lentiginous Melanoma. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
14 clinical trials at Fairfield Medical Center
·Clear filters·Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
Common conditions studied in Lancaster
- Malignant Solid Neoplasm (3 active studies)
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies)
- Acral Lentiginous Melanoma (1 active study)
- Acute Lymphoblastic Leukemia (1 active study)
- Acute Myeloid Leukemia (1 active study)
- Advanced Esophageal Adenocarcinoma (1 active study)
Leading research sponsors in Lancaster
- Alliance for Clinical Trials in Oncology
- SWOG Cancer Research Network
- National Cancer Institute (NCI)
- ECOG-ACRIN Cancer Research Group
- NRG Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Lancaster?
There are approximately 15 recruiting clinical trials in Lancaster, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Lancaster pay participants?
Most recruiting trials in Lancaster compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Lancaster?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Lancaster?
The most common conditions under active study in Lancaster include Malignant Solid Neoplasm (3), Anatomic Stage IV Breast Cancer AJCC v8 (2), Acral Lentiginous Melanoma (1), Acute Lymphoblastic Leukemia (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Lancaster?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Lancaster on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Lancaster?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Lancaster?
Recruiting research sites in Lancaster include Fairfield Medical Center, Lancaster Specialty Surgery Center, Precision Pain care, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Lancaster right now?
The largest active categories in Lancaster are Cancer & tumors (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Fairfield Medical Center?
Fairfield Medical Center is located at 401 N EWING ST, LANCASTER, OH 43130-3372. Use the Google Maps link in the intro above to get directions.
How do I contact Fairfield Medical Center?
You can reach Fairfield Medical Center by phone at (740) 687-8000. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.